Bevacizumab (Bv) in the adjuvant treatment of HER2-negative breast cancer: Final results from Eastern Cooperative Oncology Group E5103 Meeting Abstract
| Authors: | Miller, K.; O'Neill, A. M.; Dang, C. T.; Northfelt, D. W.; Gradishar, W. J.; Goldstein, L. J.; Mayer, I. A.; Brufsky, A.; Bloom, S. H.; Sparano, J. A.; Tevaarwerk, A.; Fox, K. R.; Hendricks, C. B.; Balcueva, E. P.; Sledge, G. W. |
| Abstract Title: | Bevacizumab (Bv) in the adjuvant treatment of HER2-negative breast cancer: Final results from Eastern Cooperative Oncology Group E5103 |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202275 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.500 |
| Notes: | Meeting Abstract: 500 -- Source: Wos |
